首页> 中文期刊>微创泌尿外科杂志 >经尿道膀胱肿瘤电切术治疗高龄膀胱癌合并反复性出血的应用体会

经尿道膀胱肿瘤电切术治疗高龄膀胱癌合并反复性出血的应用体会

     

摘要

Objective:The aim of this study was to evaluate the efficacy and security of transurethral resection of bladder tumor (TURBT)for bladder carcinoma with recurrent bleeding in elderly patients.Methods:62-patient were selected and treated with TURBT between May 2003 and May 2012,and all people were diagnosed as bladder transi-tional cell carcinoma by pathology after operation.Results:All people were operated a successful TURBT,without intraoperative blood transfusion or intraoperative death.Conventional postoperatively with mitomycin 40 mg was di-luted by 40 mL saline water for bladder perfusion chemotherapy.All people postoperatively information were collect-ed by telephone,and the follow-up time from 6 to 60 months,the average time was 32 months.62-patient achieved well hemostasis and significantly improved the quality of the life.Moreover,the 5-year survival rate was arrived 79.0% after TURBT.Conclusions:The effect of TURBT treatment of the bladder carcinoma patients with recurrent bleeding reached at 100%,and improved the quality of the life for therapeutic purposes.%目的::评价经尿道膀胱肿瘤电切术(transurethral resection of bladder tumor,TURBT)在治疗高龄膀胱癌合并反复性出血中的疗效及安全性.方法:2003年5月~2013年5月共收治高龄膀胱癌合并反复性出血患者62例,行TURBT治疗.结果:62例患者手术均顺利完成,无术中死亡,无术中输血;术后常规用丝裂霉素40 mg+0.9%生理盐水40 ml 进行膀胱灌注化疗.术后采用电话随访,随访时间为6~60个月,平均32个月;均能达到良好止血效果,患者生活质量明显改善,5年生存率为79.0%.结论:TURBT处理高龄膀胱癌合并反复性出血止血效果达100%,安全系数高,术后配合丝裂霉素化疗,达到治疗及改善生存质量的目的.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号